US-Canada joint inspection pilot shows savings of time-in-facility
This article was originally published in RAJ Devices
A US-Canada pilot programme involving joint quality systems inspections of medical device companies by a single third party has revealed that around 33% less total time is spent at a manufacturer's facility when compared to the combined time of inspections performed individually to satisfy the regulatory requirements of each country1,2.
You may also be interested in...
As companies undergo pharmacovigilance inspections from a growing multitude of regulatory authorities from around the globe, a senior pharmaceutical industry executive discusses how her company has been handling this complex and challenging task.
While inspection interviews can be stressful for drug firms, a Dutch pharmacovigilance inspector reassures companies that any responses made during the process cannot undo any good work they have already done. And they can also correct any wrong answers later on.
The Saudi Food & Drug Authority looks at the number of individual case safety reports (ICSRs) submitted by a company, among other risk-based factors, when drawing up its list for routine pharmacovigilance inspections.